TABLE 4.
Participant | Age (years) | Persons in household (n) | ICD‐10 | Condition | Region of origin | Hospitalization | ||
---|---|---|---|---|---|---|---|---|
At dedicated COVID‐19 unit | At intensive care | Intubation | ||||||
C1 | <18 | 4 | E70 | Phenylketonuria | Southeast | No | Yes | No |
C2 | <18 | ≥6 | E70 | Phenylketonuria | North | Yes | No | No |
C3 | <18 | 3 | E71.0 | Maple syrup urine disease | South | Yes | No | No |
C4 | <18 | ≥6 | E72.4 | Ornithine transcarbamylase deficiency | Southeast | No | Yes | No |
C5 | <18 | 4 | E75.2 | Niemann‐Pick disease type C | Northeast | Yes | No | No |
C6 | <18 | 4 | Q78.0 | Osteogenesis imperfecta | Southeast | Yes | No | No |
C7 | 18–64 | 3 | E27.1 | Addison disease | Southeast | No | Yes | No |
C8 | 18–64 | 5 | E75.2 | Niemann‐Pick disease type C | Northeast | Yes | No | No |
C9 | ≥65 | 3 | G12.2 | Amyotrophic lateral sclerosis | Southeast | No | Yes | No |
P1 | 18–64 | 4 | D83 | Common variable immunodeficiency | Southeast | Yes | No | No |
P2 | 18–64 | 5 | G12.2 | Amyotrophic lateral sclerosis | South | No | Yes | No |
P3 | 18–64 | 2 | G35 | Multiple sclerosis | North | Yes | No | No |
P4 | 18–64 | 4 | G37.3 | Acute transverse myelitis | South | Yes | No | No |
P5 | 18–64 | 3 | G71.1 | Steinert myotonic dystrophy | Northeast | No | Yes | No |
P6 | 18–64 | 4 | G71.3 | MELAS syndrome | Southeast | Yes | No | No |
P7 | 18–64 | 4 | G71.3 | Mitochondrial myopathy | South | Yes | No | No |
P8 | 18–64 | 3 | G71.3 | Mitochondrial myopathy | Southeast | No | Yes | Yes |
Abbreviations: C, caregiver; P, patient.
This table refers to the question: “Have you—or the patient you take care of—been hospitalized due to COVID‐19?”. Thus, when the questionnaire was completed by the caregiver (C1 to C9), we were unable to establish whether the patient, the caregiver, or both had COVID‐19.